Clinical Trial Update: Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Oxy/Nal tablets to Oxy PR in cancer-related pain completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Pain

Drugs mentioned

• OXY PR (Oxycodone prolonged-release)
• Oxy/Nal (oxycodone/naloxone)

Snippet

Sponsor: Mundipharma (China) Pharmaceutical Co. Ltd | Conditions: Cancer, Pain | Phase 3 | Status: COMPLETED | Results posted: 2019-09-16